Sartorius Stedim Biotech share falls nearly 3%, trailing the SBF 120 index
After breaking through the 195 € resistance level in late August, Sartorius Stedim Biotech is losing momentum this Friday and has retreated significantly below this threshold. The decline is occurring in a Paris market also oriented downward, but the magnitude of the share's movement exceeds that of the broad index.
A marked decline testing the strength of last month's bullish momentum
Sartorius Stedim Biotech is down 2.82% to 193.00 € in trading, while the SBF 120 declines by 0.33%. The share ranks among the strongest declines in the SBF 120, which contrasts with the solid gains recorded over the month: +12.27% over thirty days. This monthly gain remains intact despite today's correction, which only erases it marginally. The price is holding above its three moving averages: the MA20 at 187.78 € (variance of +2.78%), the MA50 at 181.10 € (+6.57%) and the MA200 at 182.62 € (+5.68%).
This technical cushion provides depth to the consolidation. Conversely, the share is hitting resistance at 197.90 €, which it had briefly broken through during the August 27th session, without managing to establish itself there sustainably. The 197.90 € resistance now constitutes the threshold to monitor for the trend's continuation.
Demanding valuation in an uncertain macroeconomic context for biotech companies
In terms of valuations, according to the consensus of surveyed analysts, the share is trading at approximately 38.7 times expected earnings for the current fiscal year and 32.4 times for the following fiscal year. These high multiples reflect expectations for a recovery in the biotech equipment sector, but they leave little room for disappointment. The RSI at 65 signals a configuration close to overbought conditions, consistent with the strong monthly advance, and suggests that today's selling pressure can be explained by position lightening after several weeks of gains.
The macro context remains hesitant: the CAC 40 is declining by 0.32% in trading, while the VIX falls to 14.03 (versus 15.20 the previous day), signaling a globally calm market despite geopolitical tensions in the Middle East. For Sartorius Stedim, the technical support at 162.70 € remains very distant from the current price, leaving a comfortable margin in case of further decline. The 197.90 € resistance is the next level to monitor to validate or not the resumption of the bullish trend.
